These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2541606)

  • 21. "Histiocytic markers" in melanoma.
    Pernick NL; DaSilva M; Gangi MD; Crissman J; Adsay V
    Mod Pathol; 1999 Nov; 12(11):1072-7. PubMed ID: 10574605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of a human neoplastic cell line (MFH-ino) derived from malignant fibrous histiocytoma of maxilla.
    Takahashi K; Sato K
    Hum Cell; 1991 Mar; 4(1):51-7. PubMed ID: 1653597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of tumor cells in malignant fibrous histiocytomas and other soft-tissue tumors, in comparison with malignant histiocytes. II. Immunoperoxidase study on cryostat sections.
    Roholl PJ; Kleyne J; Van Unnik JA
    Am J Pathol; 1985 Nov; 121(2):269-74. PubMed ID: 2414996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical study on the histogenesis of malignant fibrous histiocytoma].
    Tsunoda R
    Nihon Ika Daigaku Zasshi; 1996 Oct; 63(5):365-77. PubMed ID: 8937123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study on cutaneous histioproliferative lesions.
    Igisu K; Watanabe S
    Jpn J Clin Oncol; 1987 Dec; 17(4):343-51. PubMed ID: 2826848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
    Szollosi Z; Nemeth T; Egervari K; Nemes Z
    Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Presence of lysozyme and alpha 1-antichymotrypsin in tumors of the fibrous histiocytoma type. Immunohistochemical evaluation of 52 cases].
    Szklarski W; Gruchała A; Ryś J; Niezabitowski A
    Patol Pol; 1989; 40(3):261-6. PubMed ID: 2561861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunohistochemical study of malignant fibrous histiocytoma].
    Pozharisskiĭ KM; Nikitin AIu
    Arkh Patol; 1987; 49(8):11-6. PubMed ID: 2823748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiomatoid features in fibrohistiocytic sarcomas. Immunohistochemical, ultrastructural, and clinical distinction from vascular neoplasms.
    Costa MJ; McGlothlen L; Pierce M; Munn R; Vogt PJ
    Arch Pathol Lab Med; 1995 Nov; 119(11):1065-71. PubMed ID: 7487409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant fibrous histiocytoma. Heterogeneous patterns of intermediate filament proteins by immunohistochemistry.
    Miettinen M; Soini Y
    Arch Pathol Lab Med; 1989 Dec; 113(12):1363-6. PubMed ID: 2556088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast and myofibroblast participation in malignant fibrous histiocytoma (MFH) of bone. Ultrastructural study of eight cases with immunohistochemical support.
    Martorell M; Calabuig C; Peydro-Olaya A; Llombart-Bosch A; Terrier-Lacombe MJ; Contesso G
    Pathol Res Pract; 1989 Jun; 184(6):582-90. PubMed ID: 2550916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoprofile of benign and malignant fibrohistiocytic tumors.
    Regezi JA; Zarbo RJ; Tomich CE; Lloyd RV; Courtney RM; Crissman JD
    J Oral Pathol; 1987 May; 16(5):260-5. PubMed ID: 2821212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of insulin-like growth factor 1 in sarcomas.
    Roholl PJ; Skottner A; Prinsen I; Lips CJ; Den Otter W; Van Unnik JA
    Histopathology; 1990 May; 16(5):455-60. PubMed ID: 2163355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of malignant fibrous histiocytoma induced by 4-(hydroxyamino) quinoline 1-oxide in Wistar rats.
    Yamamoto H; Yamamoto I
    Kitasato Arch Exp Med; 1986 Dec; 59(4):129-38. PubMed ID: 3039235
    [No Abstract]   [Full Text] [Related]  

  • 35. Localization of CEA, HCG, lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in gastric cancer and prognosis.
    Wittekind C; Wachner R; Henke W; von Kleist S
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(5):715-24. PubMed ID: 3092465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Widespread immunoreactivity for alpha-1-antichymotrypsin in different types of tumors.
    Soini Y; Miettinen M
    Am J Clin Pathol; 1988 Aug; 90(2):131-6. PubMed ID: 2456007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum alpha-1-antitrypsin in patients with malignant tumors occurring in the oral region.
    Shirasuna K; Sugiyama M; Watatani K; Morioka S; Hayashido Y
    Int J Oral Maxillofac Surg; 1987 Aug; 16(4):516-20. PubMed ID: 2822819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lectin histochemistry of malignant fibrohistiocytic tumors.
    Ueda T; Aozasa K; Yamamura T; Tsujimoto M; Ono K; Matsumoto K
    Am J Surg Pathol; 1987 Apr; 11(4):257-62. PubMed ID: 2436495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical inflammatory histiocytic tumor of the cerebellum. A histological, immunohistochemical, and ultrastructural study.
    Figarella-Branger D; Gambarelli D; Perez-Castillo M; Regis J; Peragut JC; Pellissier JF
    Am J Surg Pathol; 1990 Aug; 14(8):778-83. PubMed ID: 2165742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of minichromosome maintenance-2 in human malignant fibrous histiocytomas: Correlations with Ki-67 and P53 expression, and apoptosis.
    Osaki M; Osaki M; Yamashita H; Shomori K; Yoshida H; Ito H
    Int J Mol Med; 2002 Aug; 10(2):161-8. PubMed ID: 12119552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.